Microbes that reside peaceably in the nasal passageways and on the skin can be harnessed for taking drugs to target cells.

In this quarter’s issue of CW EMEA, we feature four articles where politics and tech come together, including Amnesty International’s calls for Sweden’s social insurance agency to ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson & Johnson. The main ingredient for the ...

The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...

Washington, DC – United States President Donald Trump’s Middle East envoy, Steve Witkoff, has announced he will visit Gaza in the coming days as part of what he called an “inspection team ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

RIVERVIEW, Fla. (WFLA) — The Hillsborough County Sheriff’s Office is investigating a fight between middle school students that involved pepper spray. Officials say the fight started between ...

The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of depression, officials said. The FDA granted approval to Spravato (esketamine ...